HARBOR CAPITAL ADVISORS, INC.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1039128 CHICAGO, IL

Position in REGN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$725,177

-$165,676 QoQ

Shares Held

1,163

+0.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#719

of 1,322 holders

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HARBOR CAPITAL ADVISORS, INC. holds $28,134,645 across 28 Biotechnology names. REGN ranks #12 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYMR	Kymera Therapeutics, Inc.	36,368	$4,170,318
2	VCEL	Vericel Corp	72,852	$3,241,185
3	HALO	Halozyme Therapeutics, Inc.	36,977	$2,894,189
4	RARE	Ultragenyx Pharmaceutical Inc.	72,316	$2,414,631
5	CELC	Celcuity Inc.	19,933	$2,085,390
6	TARS	Tarsus Pharmaceuticals, Inc.	29,612	$1,863,779
7	AGIO	Agios Pharmaceuticals, Inc.	46,550	$1,727,470
8	SRPT	Sarepta Therapeutics, Inc.	92,669	$1,665,261

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$725,177	1,163	+0.9%	Shares	Sole	2026-08-07
2026-03-31	$890,853	1,153	-27.1%	Shares	Sole	2026-04-28
2025-12-31	$1,221,098	1,582	-0.1%	Shares	Sole	2026-01-20
2025-09-30	$890,073	1,583	+3.0%	Shares	Sole	2025-10-15
2025-06-30	$806,925	1,537	-0.6%	Shares	Sole	2025-07-09
2025-03-31	$981,153	1,547	-14.3%	Shares	Sole	2025-04-14
2023-12-31	$1,585,313	1,805	0.0%	Shares	Sole	2024-01-08
2023-09-30	$1,485,442	1,805	0.0%	Shares	Sole	2023-10-20
2023-06-30	$1,296,964	1,805	0.0%	Shares	Sole	2023-07-11
2023-03-31	$1,483,114	1,805	—	Shares	Sole	2023-04-26
No filing history on record for this holder in this stock.